OF THE
TIMES

"The US prosecution of Assange is unprecedented: he faces 175 years in prison for the same publications for which he has been nominated for the Nobel Peace Prize. This prosecution threatens the constitutional protections that Americans hold dear. By offering a pardon, to put a stop to the prosecution of Assange, your presidency will be remembered for having saved First Amendment protections for all Americans," the letter stated.The people who signed on to the statement represent nearly every corner of the globe — and the political spectrum.
Speaking on Good Morning Britain, [Pamela] Anderson claimed that she had access to Trump, and was trying to persuade him to extend a pardon to Assange.
"I know that I am in his ear," she said. "I know he is debating and we will see what happens. He has until midday on the 20th and I hope he makes that decision because I think that could add a positive to his legacy.
"I think that he is obviously against fake news and WikiLeaks is anti-fake news. It would be a perfect way to go out."
The US authorities allege that by publishing tens of thousands of classified documents about the Iraq and Afghanistan wars back in 2010, WikiLeaks and Assange placed lives in danger.
Trump is reportedly set to pardon more than 100 people before he leaves office on 20 January.
When Good Morning Britain presenter Susanna Reid voiced scepticism that Trump would be willing to extend a pardon to Assange, Anderson responded: "I have been supporting him for a very long time and freedom of speech is really important.
"I think this would be a monumental position that Trump could take, that would help with human rights and the rights of a free press because it is a very dangerous situation if we don't have a free press."
"Anita Dunn brings decades of experience managing and winning political and advocacy campaigns and advising our nation's leaders at the highest levels of government."While the exact nature of her role remains unclear, it is likely that Dunn will have wide latitude in helping craft the administration's messaging around domestic and foreign policy issues. Dunn's background in politics, having worked for Obama and former Senate Minority Leader Tom Daschle, is likely to be a benefit for her new White House post. Her private sector professional experience, however, may be another matter.

On Sunday, a 52-year-old hospital worker in Moradabad, Uttar Pradesh died a day after receiving the injection. The man's son told local media that he believed his father died from side effects of the vaccine. He said his father had a "bit of pneumonia, cough and cold" before taking the shot, but "started feeling worse" after the injection. The man later complained of congestion and chest pain and was rushed to the hospital, where he was declared dead.See also:
However, government officials claim that the individual succumbed to cardiac arrest, stressing that the fatality was "not related to the Covid-19 vaccination." An autopsy revealed that the victim suffered from blood clots and had pockets of pus in his lungs.
Notably these side effects are similar to those that killed a 'perfectly healthy' doctor in the US who had the Moderna vaccine.
The patient had been administered the Covishield vaccine and was kept in an observation room for 30 minutes after taking the shot, where he did not report any side effects, health officials claim.
This demonstrates that the devastating side effects could take days, even months, to be fully realized.
A second death was reported in Bellary in Karnataka. The 43-year-old male was vaccinated on Saturday and died on Monday. The government says the man suffered from cardiopulmonary failure. It's unclear which drug he was given. India granted emergency approval to two variants of the Covid-19 vaccine earlier this month: Bharat Biotech's Covaxin, and Covishield, a jab based on the AstraZeneca/Oxford formula and manufactured by the Serum Institute of India.
The two individuals were among seven reported cases involving severe adverse reactions to the drug following the start of a nationwide immunization drive on Saturday, according to India Today.
On Monday, Bharat Biotech issued a fact sheet which advised against taking the vaccine if a person suffers from "any allergies" or is immunocompromised.
The document also said that people with fevers or bleeding disorders should not take the jab.
India hopes to vaccinate 300 million people by August, beginning with 30 million doctors, nurses and other frontline workers. New Delhi has hailed the immunization drive, billed as the largest in the world, as a public health triumph, but lawmakers and watchdogs have accused the government of rushing approval for the two jabs. India's indigenous jab Covaxin had not yet completed phase three trials, and there have also been transparency issues surrounding Covishield.

Comment: There has been, is and will be resistance to this argument. It doesn't make it untrue. Perhaps, at this juncture, many will come to realize the truth to be more important than clinging to a comforting, but indoctrinated, fallacy.